NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.
Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.
House Members Form Group To Address Cancer Policy.
ORI Withdraws Requirement For Research Ethics Courses.
Court Upholds FDA Position On Definition Of A Drug.
GM Sends STAR Information To Its Female Employees.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
